Shinkai M, Sonoyama T, Kamitani A, Shibata RY, et al. Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study. Vaccine 2022;40:4328-4333.
PMID: 35738968